The global kidney stone management market size accounted for USD 2.73 billion in 2023 and is expected to grow around USD 4.65 billion by 2033, growing at a CAGR of 5.47% from 2024 to 2033.
Key Points
- North America dominated the kidney stone management market globally in the previous year of 2023, and it is poised to hold its position during the forecast period.
- Asia Pacific is an expanding market and is projected to hold a significant market share in 2023.
- Based on stone type, the calcium oxalate segment held the largest share in the market in 2023.
- Based on diagnostics, the ultrasound segment held a significant share of the market in 2023.
- Based on treatment, the extracorporeal shock wave lithotripsy- ESWL segment held the largest share in 2023 and dominated the kidney stone management market globally
- Based on end use, the hospitals segment held the largest market share and dominated the market.
- Based on end use, the specialty clinics segment is expected to experience the highest growth rate over the forecast period.
The kidney stone management market encompasses various medical devices and treatment options aimed at addressing the growing prevalence of kidney stones worldwide. Kidney stones, also known as renal calculi, are solid masses made up of crystals that form in the kidneys. These stones can cause severe pain and discomfort and may lead to complications if not managed effectively. The kidney stone management market offers a range of interventions, including minimally invasive procedures, lithotripsy, medication, and dietary modifications, to alleviate symptoms and prevent recurrence.
Get a Sample:https://www.precedenceresearch.com/sample/3941
Growth Factors
Several factors contribute to the growth of the kidney stone management market. One significant factor is the increasing incidence of kidney stones globally, driven by changes in dietary habits, sedentary lifestyles, and a rise in risk factors such as obesity and dehydration. Additionally, advancements in medical technology have led to the development of minimally invasive procedures, such as ureteroscopy and percutaneous nephrolithotomy (PCNL), which offer improved outcomes and reduced recovery times compared to traditional surgical interventions. Moreover, the rising prevalence of chronic kidney disease (CKD) and the association between kidney stones and CKD drive demand for effective management strategies, further propelling market growth.
Region Insights
The kidney stone management market exhibits regional variations influenced by factors such as healthcare infrastructure, prevalence of kidney stone disease, and economic conditions. Developed regions such as North America and Europe dominate the market due to higher healthcare expenditure, greater awareness about kidney stone management, and availability of advanced treatment options. In contrast, emerging economies in Asia-Pacific and Latin America are witnessing rapid market growth attributed to improving healthcare infrastructure, increasing disposable income, and rising healthcare spending. These regions also experience a higher prevalence of kidney stones due to dietary and lifestyle changes, contributing to market expansion.
Kidney Stone Management Market Scope
| Report Coverage | Details |
| Growth Rate from 2024 to 2033 | CAGR of 5.47% |
| Global Market Size in 2023 | USD 2.73 Billion |
| Global Market Size by 2033 | USD 4.65 Billion |
| Largest Market | North America |
| Base Year | 2023 |
| Forecast Period | 2024 to 2033 |
| Segments Covered | By Type of Stone, By Diagnostics Method, By Treatment, and By End-use |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Kidney Stone Management Market Dynamics
Drivers:
Several drivers propel the kidney stone management market forward. One key driver is the growing adoption of minimally invasive procedures, which offer benefits such as shorter hospital stays, reduced post-operative pain, and quicker recovery times, leading to increased patient preference and surgeon acceptance. Furthermore, the rising prevalence of risk factors such as obesity, diabetes, and hypertension contributes to the growing incidence of kidney stones, driving demand for effective management solutions. Additionally, advancements in imaging techniques such as computed tomography (CT) scans and ultrasound enable accurate diagnosis and localization of kidney stones, facilitating targeted treatment approaches and fueling market growth.
Opportunities
The kidney stone management market presents various opportunities for expansion and innovation. The increasing emphasis on preventive healthcare and patient education creates opportunities for the development of dietary and lifestyle interventions aimed at reducing the risk of kidney stone formation. Moreover, the integration of telemedicine and remote monitoring technologies allows for remote consultation and follow-up care, enhancing access to kidney stone management services in underserved areas. Additionally, collaborations between healthcare providers and medical device manufacturers facilitate the development of novel treatment modalities and the introduction of advanced technologies, driving innovation and market growth.
Challenges
Despite the promising growth prospects, the kidney stone management market faces several challenges. One significant challenge is the high cost associated with advanced treatment modalities and medical devices, limiting access to care for patients in low-income regions. Additionally, regulatory hurdles and reimbursement limitations pose challenges to market entry for new players and innovative technologies. Moreover, the lack of standardized guidelines for kidney stone management and variations in clinical practices across regions hinder the uniform adoption of treatment protocols and may lead to suboptimal outcomes. Furthermore, concerns regarding the long-term efficacy and safety of certain treatment options, such as lithotripsy and medication, underscore the need for continued research and evidence-based practices to address these challenges and improve patient outcomes.
Read Also: Facial Skincare Market Size to Touch USD 169.57 Billion by 2033
Recent Developments
- In June 2022, Olympus, a technology leader in designing and delivering innovative solutions for medical and surgical procedures, announced the launch of the SoltiveTM SuperPulsed Laser System.
- In June 2022, Dornier MedTech and Endoluxe signed a multi-year exclusive distribution contract. Dornier and Endoluxe provide products and systems targeted toward the urology market, offering innovation and value.
Kidney Stone Management Market Companies
- Cook Medical Inc. (US)
- Boston Scientific Corporation (U.S.)
- Olympus Corp. (Japan)
- C.R. Bard Inc. (U.S.)
- Storz Medical AG (Switzerland)
- Richard Wolf GmbH (Germany)
- Lumenis (Israel)
- EDAP TMS (France)
- DirexGroup (Germany)
- Elmed Electronics & Medical Industry & Trade Inc. (Turkey)
- Medi spec Ltd. (U.S.)
- Convergent Laser Technologies (U.S.)
- E.M.S. Electro Medical Systems S.A. (Switzerland)
- Dornier MedTech GmbH (Germany)
- Stryker Corp. (U.S.)
- Olympus Corp. (Japan)
Segments Covered in the Report
By Type of Stone
- Calcium oxalate
- Calcium phosphate
- Uric acid
- Cysteine
- struvite
By Diagnostics Method
- Abdominal X-Ray
- Computed Tomography
- Ultrasound
- Abdominal MRI
- Intravenous Pyelography
- Others
By Treatment
- Extracorporeal Shock Wave Lithotripsy ESWL
- Ureteroscopy
- Percutaneous Nephrolithotomy PCNL
- Others
By End-use
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centres
- Other
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.expresswebwire.com/
Blog: https://www.uswebwire.com/
Blog: https://www.dailytechbulletin.com/
Blog: https://www.autoindustrybulletin.com/
